Target intelligence / Profile preview

Ovarian tissue

Molecular classification
Other (tissue/organ)
01

Overview

Ovarian tissue refers to the functional and structural components of the ovary, a paired female reproductive organ responsible for producing oocytes and synthesizing sex hormones such as estrogen and progesterone. The ovary is composed of an outer cortex containing follicles at various developmental stages, surrounded by a dense connective tissue capsule called the tunica albuginea. The inner medulla contains blood vessels and stroma. Ovarian tissue plays a central role in female fertility through gametogenesis and hormonal regulation of the menstrual cycle. It is not itself a molecular target but rather an anatomical structure made up of multiple cell types—including granulosa cells, theca cells, stromal fibroblasts—and extracellular matrix components[1][3]. In clinical research contexts such as fertility preservation or transplantation studies, "ovarian tissue" may refer to fragments or slices used for cryopreservation or culture[6]. However, it should not be considered a therapeutic target like receptors or enzymes; instead, specific molecules within ovarian tissue—such as connective tissue growth factor (CTGF) or kinases—may serve as actual drug targets in diseases like ovarian cancer[2][4]. Note on correctness: "Ovarian tissue" is not considered a canonical therapeutic target; it is an anatomical term describing part of an organ rather than a discrete molecule such as a receptor or enzyme. Therefore, this entry should be flagged as incorrect for use in structured drug-target databases that require molecular specificity. References directly support that "ovarian tissue" describes complex multicellular structures with diverse functions but does not represent a single actionable molecular entity suitable for targeted therapy development[1][2][3].

Other names
OvaryOvarian cortexOvarian medullaOvarian stroma
02

Biological functions

Gametogenesis (oocyte production)Hormone production (estrogen and progesterone synthesis)FolliculogenesisEndocrine regulation of menstrual cycle
03

Disease associations

Cancer (ovarian cancer)Infertility
04

Safety considerations

Risk of malignancy in ovarian tissue transplantation
05

Biomarkers

Anti-Müllerian hormone (AMH)Antral follicle count (AFC)

Beyond the preview

Go deeper on Ovarian tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovarian tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call